Medical Communications

Showing 15 posts of 6408 posts found.

shutterstock_232245868

Novartis’ Zykadia smashes Phase III target for lung cancer

September 23, 2016 Medical Communications, Research and Development Novartis, lung cancer, zykadia

Novartis has announced that its cancer drug Zykadia (ceritinib) has achieved positive results in its Phase III clinical trial investigating …
shutterstock_359806121

DNA damage response biotech launches with £25m funding

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, dna damage response, funding

Cambridge-based Artios Pharma has officially launched after raising £25 million in series A financing from US and European life science …
un_assembly

193 countries sign UN declaration to fight drug-resistant infection

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jeremy Hunt, UN, drug-resistant infection

A historic UN declaration to fight drug-resistant infection across the globe has been signed by 193 countries at the United …
gilead-sciences

Gilead terminates Phase II/III study for ulcerative colitis antibody

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, ulcerative colitis

Gilead has put the brakes on a Phase II/III study of its anti-MMP9 antibody GS-5745 for the treatment of ulcerative …

AZ withdraws European filing for ovarian cancer therapy

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, EMA, cediranib, ovarian cancer

AstraZeneca is no longer seeker European approval for its oral multi-VEGF receptor inhibitor cediranib for treatment of ovarian cancer after withdrawing …
heather_bresch

EpiPen CEO appears before US lawmakers to defend “sickening” price hikes

September 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Heather Bresch, Mylan, epipen

Disgraced Mylan CEO Heather Bresch (pictured) has appeared before US lawmakers to defend the company’s now infamous and much-maligned inflation …
2363

GSK appoints Emma Walmsley as first female CEO

September 21, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, appointment

GlaxoSmithKline, the UK’s biggest drugs company, has appointed Emma Walmsley as its new CEO. Walmsley will step into the vacancy …
microsoft-80658_1280

AstraZeneca and Microsoft to develop ‘drag and drop’ cancer simulation

September 21, 2016 Medical Communications, Research and Development AstraZeneca, Digital Pharma Guide, Microsoft

AstraZeneca has entered into a partnership with tech giant Microsoft to develop a new computerised modelling system which promises to …
2363

GSK appoints Emma Walmsley as CEO

September 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, appointment

GlaxoSmithKline, the UK’s biggest drugs company, has appointed Emma Walmsley as its new CEO. Walmsley will step into the vacancy …
Ian Parsons

PCI Pharma Services to Share Expertise at Free Serialization Forum

September 19, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PCI Pharma Services

Leading pharmaceutical outsourcing services provider PCI Pharma Services, in collaboration with Xytnek, Antares, and Healthcare Packaging magazine, will host a …

Ashfield and Patient Connect Form Alliance to Provide Holistic Patient Services

September 19, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ashfield

Ashfield Commercial and Medical Services, part of UDG Healthcare plc, a global leader in providing outsourced healthcare services to pharmaceutical, …
shutterstock_141299494

Precision medicine reveals ‘Achilles heel’ in chronic myeloid leukaemia

September 16, 2016 Medical Communications University of Glasgow, chronic myeloid leukaemia

Scientists at the University of Glasgow believe they have revealed an ‘Achilles heel’ of chronic myeloid leukaemia (CML), making their …
4420456374_64a3d7e6aa

Top Ten articles in the Pharma Industry this week

September 16, 2016 Medical Communications Bayer, GSK, Gilead, GlaxoSmithKline, J&J, JJ, Pfizer, Roche, Sanofi, Takeda, aspen, google, monsanto

As we come to the end of another week, we’re looking back at an exciting week in the industry; there …
c_gajus_-_fotolia

Teva and Intel team up to tackle Huntington’s with wearable tech

September 16, 2016 Medical Communications Huntington's, Intel, Teva, wearable tech

Israeli pharma firm Teva is joining forces with technology giant Intel to tackle the debilitating disease Huntington’s with cutting-edge wearable …
shutterstock_512649

Dechra signs £31 million acquisition

September 16, 2016 Medical Communications Apex Laboratories, Dechra, acquisition

Dechra has agreed a deal to acquire veterinary pharmaceutical company Australian firm Apex Laboratories for AUS $55 (£31.3) million. The …
The Gateway to Local Adoption Series

Latest content